| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/1993 | EP0521586A1 FSH and other recombinant hormones |
| 01/07/1993 | EP0521579A2 Stick composition with sodium chloride and stearyl alcohol |
| 01/07/1993 | EP0521550A2 Vitamin D compound, method of preparing this compound and intermediate therefor |
| 01/07/1993 | EP0521524A1 Aminooxypyrrolidinylthiocarbapenem compounds |
| 01/07/1993 | EP0521471A1 Pyrimidine derivatives as HMG-CoA reductase inhibitors |
| 01/07/1993 | EP0521464A1 Antibiotic, phencomycin, a process for its production and its use |
| 01/07/1993 | EP0521463A2 Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents |
| 01/07/1993 | EP0521458A1 Mono and bis alkylamino-anthracyclines |
| 01/07/1993 | EP0521422A1 Benzomorphanes and their use as pharmaceuticals |
| 01/07/1993 | EP0521408A1 Glycopeptide antibiotics derivated from balhimycin |
| 01/07/1993 | EP0521381A1 Use of 3-pyridazinone compounds to reduce blood platelet count |
| 01/07/1993 | EP0521372A1 Use of 2,2,6,6-tetramethylpiperidine derivatives in cosmetic or dermatological compositions |
| 01/07/1993 | EP0521368A1 Bi- and tetracyclic pyrrolopyrazines |
| 01/07/1993 | EP0521353A1 Antineoplastic medicament containing octadecyl-[2-(N-methylpiperidino)-ethyl] phosphate and synthesis thereof |
| 01/07/1993 | EP0521344A2 Soluble salts of ibuprofen and naproxen with N-(2-hydroxyethyl) pyrrolidine and pharmaceutic compositions containing said salts |
| 01/07/1993 | EP0521317A2 Bathing preparation containing soluble aluminium carboxylate |
| 01/07/1993 | EP0521310A2 Solid dispersion tablets containing 1,4-dihydropyridine derivatives and process for the preparation thereof |
| 01/07/1993 | EP0521225A1 Pharmaceutical preparation for treatment of periodontitis, containing clavulanic acid |
| 01/07/1993 | EP0521203A1 Improved process for recovering organic vapors from air |
| 01/07/1993 | EP0521104A1 Method for the production of eicosapentaenoic acids |
| 01/07/1993 | EP0521070A1 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief. |
| 01/07/1993 | EP0521009A1 5-trans-prostaglandin-2-alpha as an ocular hypotensive agent |
| 01/07/1993 | EP0520987A1 METHOD OF SUPPRESSING APPETITE BY ADMINISTRATION OF TETRAHYDRO-$g(b)-CARBOLINE DERIVATIVES |
| 01/07/1993 | EP0506830A4 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
| 01/07/1993 | EP0427783A4 Silicon containing reaction product |
| 01/07/1993 | EP0390849B1 Methyl cellulose pharmaceutical composition |
| 01/07/1993 | EP0247142B1 Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same |
| 01/07/1993 | DE4220851A1 Use of thiol-substd. carboxylic acid derivatives - with activity at NMDA receptors, for treating Alzheimer's disease, panic disorder, arrhythmia, drug withdrawal symptoms, allergy, etc. |
| 01/07/1993 | DE4122240A1 Dibenz(b,e)azepinderivate und diese enthaltende arzneimittel Dibenz (b, e) and azepine derivatives containing the same drug |
| 01/07/1993 | DE4121964A1 Use of 1,4-di:hydro:pyridine derivs. - to potentiate activity of antitumoural compounds, e.g. mitoxantrone |
| 01/07/1993 | DE4121483A1 New use of quisqualate receptor antagonists |
| 01/07/1993 | DE4120991A1 Verfahren zur gewinnung der sennoside a, b und a1 A process for obtaining sennosides A, B and A1 |
| 01/07/1993 | DE4120990A1 Verfahren zur herstellung von diacetylrhein Process for the preparation of diacetylrhein |
| 01/07/1993 | CA2112496A1 Method of preventing and treating chemotherapy-induced alopecia |
| 01/07/1993 | CA2112488A1 Method and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
| 01/07/1993 | CA2112393A1 Controlled release systems and low dose androgens |
| 01/07/1993 | CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112375A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112363A1 Topical application of steroid hormones and vaginocervical stimulation to induce maternal behaviour of animals |
| 01/07/1993 | CA2112362A1 Method for treating helicobacter pylori gastritis |
| 01/07/1993 | CA2112250A1 Dimethylamino-hydroxy-alkan diphosphonic acids and pharmaceutical compositions containing them |
| 01/07/1993 | CA2111957A1 Sigma receptor ligands and the use thereof |
| 01/07/1993 | CA2111837A1 Topical composition enhancing healing of herpes lesions |
| 01/07/1993 | CA2111335A1 Azanorbornane derivatives |
| 01/07/1993 | CA2111323A1 Porphycene compounds for photodynamic therapy |
| 01/07/1993 | CA2110575A1 Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine |
| 01/07/1993 | CA2110574A1 Tryptamine analogues, their synthesis and their use as 5-ht1-like or 5-ht2 receptor agonists |
| 01/07/1993 | CA2054440A1 Pharmaceutical formulations |
| 01/06/1993 | CN1067658A Cephem compounds |
| 01/06/1993 | CN1067657A Process for preparing b-lactam compound |
| 01/06/1993 | CN1067656A Aminomethyl-substituted 2,3-dihydropyrano (2,3-b) pyridines, process for their preparation and their use in medicaments |
| 01/06/1993 | CN1067655A Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 01/06/1993 | CN1067654A Processes for diastereoselective synthesis of nucleosides |
| 01/06/1993 | CN1067652A Process for preparation of high-purity 1-(3-chlorophenyl)-4-methyl-7.8-dimethoxy-5h-2,3-benzodiazep |
| 01/06/1993 | CN1067580A Megestrol acetate formulation |
| 01/06/1993 | CN1067579A Non-chlorofluorocarbon aerosol formulations |
| 01/06/1993 | CN1067578A Non-chlorofluorocarbon aerosol formulations |
| 01/06/1993 | CN1067577A Pharmaceutical formulations |
| 01/06/1993 | CA2073141A1 Ophthalmic compositions |
| 01/06/1993 | CA2073117A1 Blood platelet-decreasing therapeutic drug |
| 01/06/1993 | CA2072676A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 01/05/1993 | WO1993001194A1 1,2,4-THIADIAZINO[3,4-b]BENZOTHIAZOLE DERIVATIVES, THEIR PREPARATION, AND DRUGS CONTAINING SAME |
| 01/05/1993 | US5177257 Racemic separation, quinine salt formation |
| 01/05/1993 | US5177242 Process for preparing optically active cyanohydrins with enzymes |
| 01/05/1993 | US5177198 Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates |
| 01/05/1993 | US5177113 Free-standing, porous foam PVP:H2 O2 product |
| 01/05/1993 | US5177110 Injectable parasiticidal composition |
| 01/05/1993 | US5177108 Aryloxy alkanols as anti-retrovirus agents |
| 01/05/1993 | US5177105 Methods for controlling intraocular pressure with transition metal complexes |
| 01/05/1993 | US5177104 6-α-hydroxy derivatives of mevinic acids |
| 01/05/1993 | US5177102 Polyisoprene compounds and salts thereof |
| 01/05/1993 | US5177091 Use of carbazones as novel active ingredients in medicaments |
| 01/05/1993 | US5177088 Cognition Activators |
| 01/05/1993 | US5177087 Cyclic amine compounds and their use |
| 01/05/1993 | US5177086 Phenyl-3-aminoalkyl-4-methyl-2,6-dioxopiperidines |
| 01/05/1993 | US5177085 Dihydro-isoquinoline derivatives, processes for their production, pharmaceutical compositions containing them, and their use in treating asthma |
| 01/05/1993 | US5177083 Drugs effective against retroviruses |
| 01/05/1993 | US5177081 Method and pharmaceutical composition for the treatment of schizophrenia |
| 01/05/1993 | US5177080 Substituted pyridyl-dihydroxy-heptenoic acid and its salts |
| 01/05/1993 | US5177079 Antiallergen, antiulcer |
| 01/05/1993 | US5177078 Piperazine derivatives |
| 01/05/1993 | US5177076 Aqueous folinate solution stable at refrigerator temperature, as well as process for its preparation |
| 01/05/1993 | US5177075 Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process |
| 01/05/1993 | US5177074 Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| 01/05/1993 | US5177071 Tranquilizers |
| 01/05/1993 | US5177070 Administering galanthamine |
| 01/05/1993 | US5177067 Substituted aminoalkyl biphenyl compounds and method of treating fungal infections |
| 01/05/1993 | US5177065 Fructose or ribose, starch hydrolyzate, film-forming agent |
| 01/05/1993 | US5177064 Targeted drug delivery via phosphonate derivatives |
| 01/05/1993 | US5177063 Avermectin compounds with a 6,5-spiroketal ring system |
| 01/05/1993 | US5177062 Method for treating immune complex diseases with n-acetylneuraminic acid |
| 01/05/1993 | US5176919 Pharmaceutical compositions having activity on the cutaneous microcirculation |
| 01/05/1993 | US5176716 Hydroxytriaminopyrimidine developer |
| 01/05/1993 | CA2102318A1 1,2,4-thiadiazino[3,4-b]benzothiazole derivatives, their preparation and drugs containing them |
| 01/05/1993 | CA2073111A1 Cycloalkyltriols containing cyclic substituents, processes and intermediate products for their preparation and their use as antiviral and antiparasitic agents |
| 01/05/1993 | CA2072911A1 Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives |
| 01/05/1993 | CA1312336C Aromatic polycyclic derivatives, their preparation process and their use in human and veterinary medicine as well as in cosmetics |
| 01/05/1993 | CA1312333C Strontium salt, its preparation process and the pharmaceutical compositions containing it |
| 01/05/1993 | CA1312331C Phosphone- and phosphonoalkyl-azacycloalk(en)yl carboxylic acid compounds |
| 01/05/1993 | CA1312330C Heterocyclic compounds, a process for their preparation and their use in medicine |